Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totaling 28 shares, a drop of 56.9% from the September 30th total of 65 shares. Based on an average trading volume of 1,902 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are sold short.
Innovator IBD Breakout Opportunities ETF Price Performance
NYSEARCA BOUT opened at $40.62 on Friday. The stock has a market capitalization of $14.22 million, a P/E ratio of 28.69 and a beta of 1.04. Innovator IBD Breakout Opportunities ETF has a one year low of $35.05 and a one year high of $49.41. The business has a 50 day simple moving average of $43.05 and a 200 day simple moving average of $43.38.
About Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
Further Reading
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- LyondellBasell’s Dividend Looks Safer, But a New Risk Could Change That
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
